Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Biotechnology Fund

+ Add to Watchlist

RYOIX:US

93.00 USD 0.88 0.96%

As of 09:29:30 ET on 03/02/2015.

Snapshot for Rydex Series - Biotechnology Fund (RYOIX)

Year To Date: +13.15% 3-Month: +12.81% 3-Year: +40.14% 52-Week Range: 58.91 - 93.06
1-Month: +7.49% 1-Year: +25.07% 5-Year: +29.05% Beta vs SPX: 0.97

Mutual Fund Chart for RYOIX

No chart data available.
  • RYOIX:US 93.00
  • 1M
  • 1Y
Interactive RYOIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYOIX

Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.

Inception Date: 04-01-1998 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / RYAN HARDER
Web Site: www.guggenheiminvestments.com

Fundamentals for RYOIX

NAV (on 2015-03-02) 93.00
Assets (M) (on 2015-03-02) 667.69
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYOIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-11-18) 2.57
Dividend Yield (ttm) 3.40

Fees & Expenses for RYOIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.36

Top Fund Holdings for RYOIX

Filing Date: 01/31/2015
Name Position Value % of Total
Gilead Sciences Inc 384,442 40,301,055 6.886%
Biogen Idec Inc 85,501 33,273,569 5.685%
Amgen Inc 216,144 32,910,085 5.623%
Celgene Corp 267,685 31,897,345 5.450%
Regeneron Pharmaceuticals Inc 50,614 21,088,829 3.603%
Alexion Pharmaceuticals Inc 105,502 19,332,186 3.303%
Illumina Inc 88,023 17,181,209 2.936%
Vertex Pharmaceuticals Inc 148,370 16,341,472 2.792%
BioMarin Pharmaceutical Inc 131,544 12,780,815 2.184%
Pharmacyclics Inc 75,300 12,706,875 2.171%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil